- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/00 - Drugs for immunological or allergic disorders
Patent holdings for IPC class A61P 37/00
Total number of patents in this class: 8674
10-year publication summary
|
331
|
354
|
491
|
637
|
656
|
603
|
737
|
678
|
594
|
163
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
290 |
| Bristol-myers Squibb Company | 4848 |
145 |
| F. Hoffmann-La Roche AG | 7889 |
131 |
| Novartis AG | 11041 |
121 |
| Genentech, Inc. | 3888 |
75 |
| Incyte Corporation | 994 |
74 |
| Boehringer Ingelheim International GmbH | 4729 |
60 |
| Hoffmann-La Roche Inc. | 3341 |
58 |
| Merck Patent GmbH | 5826 |
52 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
48 |
| Glaxo Group Limited | 4190 |
44 |
| Takeda Pharmaceutical Company Limited | 2702 |
43 |
| AstraZeneca AB | 2940 |
40 |
| Janssen Pharmaceutica N.V. | 3437 |
40 |
| Glaxosmithkline Intellectual Property Development Limited | 736 |
39 |
| The Regents of the University of California | 19661 |
38 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
34 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 615 |
34 |
| Bayer Pharma AG | 1058 |
33 |
| Sanofi | 3984 |
31 |
| Other owners | 7244 |